These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 23701334)
21. Antifungal susceptibility of Candida albicans in biofilms. Tobudic S; Kratzer C; Lassnigg A; Presterl E Mycoses; 2012 May; 55(3):199-204. PubMed ID: 21793943 [TBL] [Abstract][Full Text] [Related]
22. Biofilm inhibition by Cymbopogon citratus and Syzygium aromaticum essential oils in the strains of Candida albicans. Khan MS; Ahmad I J Ethnopharmacol; 2012 Mar; 140(2):416-23. PubMed ID: 22326355 [TBL] [Abstract][Full Text] [Related]
23. Role of filamentation in Galleria mellonella killing by Candida albicans. Fuchs BB; Eby J; Nobile CJ; El Khoury JB; Mitchell AP; Mylonakis E Microbes Infect; 2010 Jun; 12(6):488-96. PubMed ID: 20223293 [TBL] [Abstract][Full Text] [Related]
24. Caspofungin primes the immune response of the larvae of Galleria mellonella and induces a non-specific antimicrobial response. Kelly J; Kavanagh K J Med Microbiol; 2011 Feb; 60(Pt 2):189-196. PubMed ID: 20947665 [TBL] [Abstract][Full Text] [Related]
25. Inhibition of Candida albicans biofilm formation and yeast-hyphal transition by 4-hydroxycordoin. Messier C; Epifano F; Genovese S; Grenier D Phytomedicine; 2011 Mar; 18(5):380-3. PubMed ID: 21353508 [TBL] [Abstract][Full Text] [Related]
26. Lactobacillus species increase the survival of Galleria mellonella infected with Candida albicans and non-albicans Candida clinical isolates. Santos RB; Scorzoni L; Namba AM; Rossoni RD; Jorge AOC; Junqueira JC Med Mycol; 2019 Apr; 57(3):391-394. PubMed ID: 29796666 [TBL] [Abstract][Full Text] [Related]
27. New antifungal 4-chloro-3-nitrophenyldifluoroiodomethyl sulfone reduces the Candida albicans pathogenicity in the Galleria mellonella model organism. Staniszewska M; Gizińska M; Kazek M; de Jesús González-Hernández R; Ochal Z; Mora-Montes HM Braz J Microbiol; 2020 Mar; 51(1):5-14. PubMed ID: 31486049 [TBL] [Abstract][Full Text] [Related]
28. Adaptation of a Gaussia princeps Luciferase reporter system in Candida albicans for in vivo detection in the Galleria mellonella infection model. Delarze E; Ischer F; Sanglard D; Coste AT Virulence; 2015; 6(7):684-93. PubMed ID: 26305489 [TBL] [Abstract][Full Text] [Related]
29. Towards non-invasive monitoring of pathogen-host interactions during Candida albicans biofilm formation using in vivo bioluminescence. Vande Velde G; Kucharíková S; Schrevens S; Himmelreich U; Van Dijck P Cell Microbiol; 2014 Jan; 16(1):115-30. PubMed ID: 23962311 [TBL] [Abstract][Full Text] [Related]
30. In vitro interactions of anidulafungin with azole antifungals, amphotericin B and 5-fluorocytosine against Candida species. Karlowsky JA; Hoban DJ; Zhanel GG; Goldstein BP Int J Antimicrob Agents; 2006 Feb; 27(2):174-7. PubMed ID: 16414247 [TBL] [Abstract][Full Text] [Related]
31. Clinical isolates and laboratory reference Candida species and strains have varying abilities to form biofilms. Alnuaimi AD; O'Brien-Simpson NM; Reynolds EC; McCullough MJ FEMS Yeast Res; 2013 Nov; 13(7):689-99. PubMed ID: 23927631 [TBL] [Abstract][Full Text] [Related]
32. The European Confederation of Medical Mycology (ECMM) survey of candidaemia in Italy: in vitro susceptibility of 375 Candida albicans isolates and biofilm production. Tortorano AM; Prigitano A; Biraghi E; Viviani MA; J Antimicrob Chemother; 2005 Oct; 56(4):777-9. PubMed ID: 16144871 [TBL] [Abstract][Full Text] [Related]
33. [Anti-candidal activity of clinical Pseudomonas aeruginosa strains and in vitro inhibition of Candida biofilm formation]. Keçeli Özcan S; Dündar D; Sönmez Tamer G Mikrobiyol Bul; 2012 Jan; 46(1):39-46. PubMed ID: 22399170 [TBL] [Abstract][Full Text] [Related]
34. Clinical strains of Lactobacillus reduce the filamentation of Candida albicans and protect Galleria mellonella against experimental candidiasis. Rossoni RD; Dos Santos Velloso M; Figueiredo LMA; Martins CP; Jorge AOC; Junqueira JC Folia Microbiol (Praha); 2018 May; 63(3):307-314. PubMed ID: 29170992 [TBL] [Abstract][Full Text] [Related]
35. Anti-biofilm activity of antibody directed against surface antigen complement receptor 3-related protein-comparison of Candida albicans and Candida dubliniensis. Chupácová J; Borghi E; Morace G; Los A; Bujdáková H Pathog Dis; 2018 Feb; 76(1):. PubMed ID: 29315379 [TBL] [Abstract][Full Text] [Related]
36. Biofilms of non-Candida albicans Candida species: quantification, structure and matrix composition. Silva S; Henriques M; Martins A; Oliveira R; Williams D; Azeredo J Med Mycol; 2009 Nov; 47(7):681-9. PubMed ID: 19888800 [TBL] [Abstract][Full Text] [Related]
37. Effect of exogenous administration of Candida albicans autoregulatory alcohols in a murine model of hematogenously disseminated candidiasis. Martins M; Lazzell AL; Lopez-Ribot JL; Henriques M; Oliveira R J Basic Microbiol; 2012 Aug; 52(4):487-91. PubMed ID: 22052380 [TBL] [Abstract][Full Text] [Related]
38. Conditions for optimal Candida biofilm development in microtiter plates. Krom BP; Cohen JB; McElhaney-Feser G; Busscher HJ; van der Mei HC; Cihlar RL Methods Mol Biol; 2009; 499():55-62. PubMed ID: 19152039 [TBL] [Abstract][Full Text] [Related]
39. [Susceptibility to antifungal agents of Candida sp. and biofilm formation]. Ciok-Pater E; Białucha A; Gospodarek E; Ostafin A Med Dosw Mikrobiol; 2011; 63(2):171-87. PubMed ID: 22184912 [TBL] [Abstract][Full Text] [Related]
40. Wax moth larva (Galleria mellonella): an in vivo model for assessing the efficacy of antistaphylococcal agents. Desbois AP; Coote PJ J Antimicrob Chemother; 2011 Aug; 66(8):1785-90. PubMed ID: 21622972 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]